• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics

tetano

Editor, Senior Moderator
Nat Commun


. 2020 Oct 2;11(1):4968.
doi: 10.1038/s41467-020-18786-x.
Early prediction of disease progression in COVID-19 pneumonia patients with chest CT and clinical characteristics


Zhichao Feng[SUP] 1 [/SUP], Qizhi Yu[SUP] 2 3 [/SUP], Shanhu Yao[SUP] 1 [/SUP], Lei Luo[SUP] 1 [/SUP], Wenming Zhou[SUP] 4 [/SUP], Xiaowen Mao[SUP] 5 [/SUP], Jennifer Li[SUP] 6 [/SUP], Junhong Duan[SUP] 1 [/SUP], Zhimin Yan[SUP] 1 [/SUP], Min Yang[SUP] 1 [/SUP], Hongpei Tan[SUP] 1 [/SUP], Mengtian Ma[SUP] 1 [/SUP], Ting Li[SUP] 1 [/SUP], Dali Yi[SUP] 1 [/SUP], Ze Mi[SUP] 1 [/SUP], Huafei Zhao[SUP] 1 [/SUP], Yi Jiang[SUP] 1 [/SUP], Zhenhu He[SUP] 1 [/SUP], Huiling Li[SUP] 1 [/SUP], Wei Nie[SUP] 1 [/SUP], Yin Liu[SUP] 1 [/SUP], Jing Zhao[SUP] 1 [/SUP], Muqing Luo[SUP] 1 [/SUP], Xuanhui Liu[SUP] 7 [/SUP], Pengfei Rong[SUP] 8 9 [/SUP], Wei Wang[SUP] 10 11 [/SUP]



Affiliations

Abstract

The outbreak of coronavirus disease 2019 (COVID-19) has rapidly spread to become a worldwide emergency. Early identification of patients at risk of progression may facilitate more individually aligned treatment plans and optimized utilization of medical resource. Here we conducted a multicenter retrospective study involving patients with moderate COVID-19 pneumonia to investigate the utility of chest computed tomography (CT) and clinical characteristics to risk-stratify the patients. Our results show that CT severity score is associated with inflammatory levels and that older age, higher neutrophil-to-lymphocyte ratio (NLR), and CT severity score on admission are independent risk factors for short-term progression. The nomogram based on these risk factors shows good calibration and discrimination in the derivation and validation cohorts. These findings have implications for predicting the progression risk of COVID-19 pneumonia patients at the time of admission. CT examination may help risk-stratification and guide the timing of admission.
 
Back
Top Bottom